Barclays PLC increased its position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) by 1,792.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 189,290 shares of the biotechnology company’s stock after acquiring an additional 179,290 shares during the quarter. […]